Medicamap: Pharmacogenetic Testing to Guide Cardiovascular Therapy

Medicamap: Pharmacogenetic Testing to Guide Cardiovascular Therapy

Cardiovascular disease (CVD) is the leading cause of death globally — and in India, CVD accounts for approximately one-fifth of all deaths. Managing CVD effectively requires not just the right diagnosis, but the right medication at the right dose for each individual patient. This is where pharmacogenomics — and Medicamap — make a critical difference.

Why Drug Response Varies Between Patients

Two patients with the same diagnosis, prescribed the same cardiovascular drug at the same dose, can have very different outcomes — one responds well, another experiences side effects, and a third sees no benefit at all. The primary reason is genetics. Variants in genes encoding drug-metabolising enzymes (CYP2C9, CYP2C19, CYP3A4, CYP2D6) and drug transporters determine how quickly your body processes a medication — affecting its efficacy and safety.

Key Cardiovascular Drug Classes Covered by Medicamap

• Statins (atorvastatin, rosuvastatin, simvastatin) — genetic variants in SLCO1B1 and CYP3A4 affect statin metabolism and risk of statin-induced myopathy

• Antiplatelet agents (clopidogrel, aspirin) — CYP2C19 variants determine whether clopidogrel is activated effectively; poor metabolisers have higher risk of cardiovascular events

• Anticoagulants (warfarin) — VKORC1 and CYP2C9 variants determine warfarin sensitivity and optimal dosing; incorrect dosing can cause bleeding or clotting

• Beta blockers (metoprolol, carvedilol) — CYP2D6 variants affect beta blocker metabolism and blood pressure response

• ACE inhibitors and ARBs — genetic variants influence blood pressure response and risk of side effects like ACE inhibitor-induced cough

How Medicamap Helps

Medicamap by MapmyGenome is a state-of-the-art pharmacogenomic test that analyses your drug-response profile based on your genetic makeup. It covers almost 100 FDA-approved drugs across 20+ drug classes — including all major cardiovascular drug classes. With Medicamap, your cardiologist can prescribe the right cardiovascular drug at the right dose for you — based on your genetic profile rather than trial and error.